Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report

doi:10.12998/wjcc.v8.i23.6048

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5432)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

418

WORD

183

HTML

3056

Figures (1-3)

169

Tables (1-2)

168

Sum=3994

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

438

Download

1000

Sum=1438

Dec 6, 2020 (publication date) through Jul 18, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Dec 6, 2020; 8(23): 6048-6055
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.6048

Full Size Figure Download Figure

Figure 2 Hemoglobin changes from baseline after treatment with oral roxadustat.

Citation: Yu WH, Li XJ, Yuan F. Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report. World J Clin Cases 2020; 8(23): 6048-6055
URL: https://www.wjgnet.com/2307-8960/full/v8/i23/6048.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i23.6048